Aurubis AG (ETR:NDA) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Aurubis AG (ETR:NDA) came out with its second-quarter results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following this report. It was a credible result overall, with revenues of €5.0b and statutory earnings per share of €9.53 both in line with analyst estimates, showing that Aurubis is executing in line with expectations. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
Our free stock report includes 2 warning signs investors should be aware of before investing in Aurubis. Read for free now.Taking into account the latest results, the current consensus from Aurubis' eight analysts is for revenues of €19.3b in 2025. This would reflect a reasonable 6.4% increase on its revenue over the past 12 months. Before this earnings report, the analysts had been forecasting revenues of €18.4b and earnings per share (EPS) of €6.32 in 2025. The thing that stands out most is that, while there's been a small lift in revenue estimates, the consensus no longer provides an EPS estimate. This impliesthat revenue is more important following the latest results.
View our latest analysis for Aurubis
There's been no real change to the consensus price target of €75.22, with Aurubis seemingly executing in line with expectations. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Aurubis at €90.00 per share, while the most bearish prices it at €54.00. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.
One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. The analysts are definitely expecting Aurubis' growth to accelerate, with the forecast 13% annualised growth to the end of 2025 ranking favourably alongside historical growth of 5.8% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 2.2% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Aurubis is expected to grow much faster than its industry.
The Bottom Line
The highlight for us was that the analysts increased their revenue forecasts for Aurubis next year. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
At least one of Aurubis' eight analysts has provided estimates out to 2027, which can be seen for free on our platform here.
It is also worth noting that we have found 2 warning signs for Aurubis (1 is significant!) that you need to take into consideration.
Valuation is complex, but we're here to simplify it.
Discover if Aurubis might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.